Abstract

Different kinds of medical technologies and biotechnologies have all been developed for “therapeutic purposes,” but the possible uses of these technologies are not restricted to therapy. These possibilities give rise to a number of questions. This chapter discusses whether mood enhancement is a legitimate goal of medicine when medical resources are limited and the medical enterprise is publicly funded. It focusses on the case of mood enhancement through so‐called cosmetic psychopharmaceuticals. It suggests that we should give absolute priority to those who suffer most; we should give equal weight to all improvements in well‐being, regardless of where on the scale they occur; the better a person feels, the less is the value of a certain improvement; once a certain level of subjective well‐being is achieved, further improvement is worth nothing from a medical perspective, and an improvement beyond normal mood still has value, but it is worth less.